关键词: Cilostazol antiplatelet therapy capsular warning syndrome cardio-embolic stroke

Mesh : Aged, 80 and over Female Humans Anticoagulants / adverse effects Cilostazol Embolic Stroke / complications drug therapy Fibrinolytic Agents Infarction, Middle Cerebral Artery Stroke / complications Syndrome Tissue Plasminogen Activator / therapeutic use

来  源:   DOI:10.5692/clinicalneurol.cn-001927

Abstract:
An 88-year-old woman with atrial fibrillation was admitted to our hospital due to the right hemiplegia and aphasia. MRA shows the left middle cerebral artery M2 occlusion. After intravenous rt-PA, her symptoms improved. She was diagnosed with cardioembolic stroke, and was treated with direct oral anticoagulation therapy. However, she had repeated stereotypical transient right hemiparesis a week after index stroke. Her symptoms were considered capsular warning syndrome (CWS). After cilostazol was administered, no further transient neurological deteriorations occurred. CWS can coexist with acute cardioembolic stroke, and cilostazol was effective.
摘要:
一名88岁的房颤患者因右偏瘫和失语症入院。MRA显示左侧大脑中动脉M2闭塞。静脉注射rt-PA后,她的症状有所改善。她被诊断出心源性中风,并接受直接口服抗凝治疗。然而,她在索引性卒中后一周反复出现刻板的短暂性右侧偏瘫.她的症状被认为是包膜警告综合征(CWS)。服用西洛他唑后,没有进一步的短暂性神经恶化发生。CWS可与急性心源性卒中共存,西洛他唑有效.
公众号